Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

InflaRx $50 million at-the-market offering
Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by InflaRx N.V. of its shares of common stock for up to an aggregate amount of $50…
Inventiva $108 million U.S. IPO and Nasdaq listing
Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S.A.’s 7,478,261 American Depositary Shares. Aggregate gross…
Centogene $49 million follow-on offering
Davis Polk advised Centogene N.V. on its $49 million follow-on public offering of 3,500,000 of its common shares, consisting of 2,000,000 common shares offered by Centogene and 1,500,000…
ING Groep $1 billion green bond offering
Davis Polk advised the lead managers in connection with a Rule 144A/Reg S green bond offering by ING Groep N.V. of $1 billion aggregate principal amount of 1.400% callable fixed-to-fixed…
Oryzon Genomics €20 million private placement
Davis Polk advised Oryzon Genomics, S.A. on its private placement of approximately 7,273,000 of its ordinary shares pursuant to a capital increase. The offering consisted of two tranches: a…
RMB Holdings spinoff of FirstRand
Davis Polk is advising RMB Holdings Limited as to U.S. law in connection with its unbundling via spin-off of its interest in FirstRand Limited, a South African financial institution. As…
Back to top